5 Pharmaceutical Stocks to Buy According to Timothy Lynch’s Stonepine Capital

Page 5 of 5

1. Amryt Pharma plc (NASDAQ:AMYT)

Stonepine Capital’s Stake Value: $33.937 million

Percentage of Stonepine Capital’s 13F Portfolio: 17.74%

Number of Hedge Fund Holders: 11

Amryt Pharma plc (NASDAQ: AMYT), headquartered in the United Kingdom, is a biopharmaceutical company dedicated to providing treatments to people with rare, debilitating diseases. Since its inception in 2015, the company has commercialized three products.

In Amryt Pharma plc (NASDAQ: AMYT), Stonepine Capital owns over 2.7 million shares. The investment covers 17.74% of the fund’s portfolio. Interestingly, Stonepine Capital has increased its stake in the company by 11% since the previous quarter, which indicates that the company has good prospects.

At the end of the second quarter, there were 11 hedge funds in Insider Monkey’s database that held stakes in Amryt Pharma plc (NASDAQ: AMYT) as compared to 8 hedge funds in the first quarter. Timothy Lynch’s Stonepine Capital owns over 2.79 million shares of Amryt Pharma plc (NASDAQ: AMYT) which amounts to a worth of $33.937 million.

You can also take a peek at the 15 Dividend Stocks People Buy for Early Retirement and 10 Best Tech ETFs to Buy According to Reddit.

Page 5 of 5